PRS6 A CANADIAN COST ANALYSIS OF 4 RANDOMIZED DOUBLEBLIND ACTIVE COMPARATOR TRIALS WITH TELITHROMYCIN IN ACUTE EXACERBATION OF CHRONIC BRONCHITIS (AECB) AND COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65930-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)65930-X/fulltext
Title :
PRS6 A CANADIAN COST ANALYSIS OF 4 RANDOMIZED DOUBLEBLIND ACTIVE COMPARATOR TRIALS WITH TELITHROMYCIN IN ACUTE EXACERBATION OF CHRONIC BRONCHITIS (AECB) AND COMMUNITY-ACQUIRED PNEUMONIA (CAP)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65930-X&doi=10.1016/S1098-3015(10)65930-X
First page :
Section Title :
Open access? :
No
Section Order :
297